University research records
Semnan University of Medical Sciences
8 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →8 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Semnan University of Medical Sciences are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–8 of 8 matching records. Counts update as records arrive.
The effects of combination therapy with Glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporters 2 inhibitors on cardiometabolic indices: A GRADE assessed systematic review and meta-analysis
September 3, 2026 · 0 citations · Open access
Open original record →Exploring the pathophysiological links between obesity, diabetes, and myocardial dysfunction: an in-depth narrative review
December 4, 2025 · 5 citations · Open access
Open original record →Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats
June 1, 2023 · 32 citations · Open access
Open original record →Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
March 19, 2023 · 8 citations · Open access
Open original record →Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu
February 3, 2023 · 7 citations · Open access
Open original record →Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art
September 29, 2022 · 33 citations · Open access
Open original record →Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review
November 22, 2019 · 94 citations · Open access
Open original record →The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: An update
November 8, 2019 · 29 citations · Open access
Open original record →